A study on VMX-C001 for urgent surgery while on blood thinners
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need urgent surgery that has a high risk of bleeding.
- You must be taking a Factor Xa blood thinner (like apixaban or rivaroxaban) and have a significant level of it in your blood.
- You must be willing to use reliable birth control if you can become pregnant or father a child.
- You cannot have other conditions that increase bleeding risk, be on certain other blood thinners, or have certain health problems like severe infection or shock.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests TAK-330, a reversal (blocking) medicine, to reduce bleeding risk during urgent surgery for adults taking Factor Xa inhibitors like rivaroxaban, apixaban, or edoxaban. It’s for situations where surgery can’t wait and doctors need a fast way to restore normal clotting.
This trial compares the blood thinner apixaban to warfarin for treating blood clots in the main pumping chamber of the heart (left ventricle). The goal is to see which medicine is better at preventing strokes and other complications.
This trial tests whether a direct oral anticoagulant (a blood thinner) can reduce pain from venous malformations that also cause a blood clotting problem (localized intravascular coagulation, or LIC). It may help people whose pain interferes with daily activities or sleep.
This study looks at Ondexxya, a medicine used to reverse the effect of certain blood thinners during a dangerous bleeding emergency. It may help doctors better understand how to manage life-threatening bleeding caused by apixaban, rivaroxaban, or edoxaban.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
Hear when a new Blood Loss, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.